Synterex Revenue and Competitors

Dedham, MA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Synterex's estimated annual revenue is currently $6M per year.(i)
  • Synterex's estimated revenue per employee is $155,000

Employee Data

  • Synterex has 39 Employees.(i)
  • Synterex grew their employee count by -5% last year.

Synterex's People

NameTitleEmail/Phone
1
President and ownerReveal Email/Phone
2
Executive Director, Medical Writing & Quality AssuranceReveal Email/Phone
3
Information Technology ManagerReveal Email/Phone
4
Medical WriterReveal Email/Phone
5
Strategic Medical WriterReveal Email/Phone
6
Principal Medical WriterReveal Email/Phone
7
Quality Control LeadReveal Email/Phone
8
Quality Control AssociateReveal Email/Phone
9
Accounting AssistantReveal Email/Phone
10
Business Operations AssociateReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Synterex?

Synterex is a woman-owned, disability-owned business that provides clinical solutions, including publishing, clinical science, project management, medical and regulatory writing services, and IT collaboration services, from process development and optimization to document production. Our staffers are seasoned and dedicated, with extensive experience doing the work hands-on as well as building and leading teams. We are committed to applying our years of experience and current regulatory knowledge to help clients get their documents on the path to approval, thereby delivering important new therapies to patients in an expedient manner. We have a proven ability to provide strategic direction across a broad spectrum of therapeutic areas. Areas of therapeutic experience include (but are not limited to): - Oncology (heme, solid tumor) - Immuno-oncology - Vaccines - Gene therapy - Oncology supportive care - CNS - Radiopharmaceuticals - Ophthalmology - Allergy-related disorders - Rare disease - Inflammation - Multiple sclerosis - Generics - Biologics - Opioids/pain management - Obesity and metabolism - Sleep disorders - Orthopedics - Infectious disease (including COVID-19)

keywords:N/A

N/A

Total Funding

39

Number of Employees

$6M

Revenue (est)

-5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.6M40N/AN/A
#2
$3.5M467%N/A
#3
$10.8M509%N/A
#4
$10.2M6530%N/A
#5
$8.9M6819%N/A